Medpace
MEDP
623 hedge funds and large institutions have $10.4B invested in Medpace in 2024 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 239 increasing their positions, 234 reducing their positions, and 43 closing their positions.
77% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 43
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
4% more funds holding
Funds holding: 597 → 623 (+26)
2% more repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 234
1% more capital invested
Capital invested by funds: $10.2B → $10.4B (+$147M)
0.08% more ownership
Funds ownership: 82.28% → 82.37% (+0.08%)
51% less call options, than puts
Call options by funds: $17.3M | Put options by funds: $35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Westwind Capital
Las Cruces,
New Mexico
|
+$134M |
| 2 |
FPP
Findlay Park Partners
London,
United Kingdom
|
+$100M |
| 3 |
Goldman Sachs
New York
|
+$57.9M |
| 4 |
ClearBridge Investments
New York
|
+$56.8M |
| 5 |
Renaissance Technologies
New York
|
+$48.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
-$61.7M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$51.5M |
| 3 |
Morgan Stanley
New York
|
-$50M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$48.6M |
| 5 |
CCM
Channing Capital Management
Chicago,
Illinois
|
-$44.8M |
MEDP Hedge Fund Activity: Q2 2024 in Review
623 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2024, worth a combined $10.4B — up 1.4% from $10.2B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new MEDP positions and 43 closed out — a net gain of 33 holders — while 239 added to existing stakes and 234 trimmed.
The largest buyer was Westwind Capital, adding an estimated $134M. The largest seller was Prudential Financial, cutting an estimated $61.7M.
- 623 institutional investors held Medpace (MEDP) as of Q2 2024, up from 597 in Q1 2024.
- Funds reported $10.4B of Medpace stock for Q2 2024, up 1.4% quarter-over-quarter.
- 76 funds opened new Medpace positions in Q2 2024 and 43 closed out, a net change of +33 holders.
- The largest Medpace buyer in Q2 2024 was Westwind Capital, an estimated $134M added.
- The largest Medpace seller in Q2 2024 was Prudential Financial, an estimated $61.7M sold.
Based on aggregated 13F filings for Q2 2024.